UGI CORP /PA/ Annual Operating Income (Loss) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ugi Corp /Pa/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Ugi Corp /Pa/ Operating Income (Loss) for the quarter ending September 30, 2024 was -$246M, a 204% decline year-over-year.
  • Ugi Corp /Pa/ Operating Income (Loss) for the twelve months ending September 30, 2024 was $770M.
  • Ugi Corp /Pa/ annual Operating Income (Loss) for 2024 was $770M.
  • Ugi Corp /Pa/ annual Operating Income (Loss) for 2023 was -$1.44B, a 187% decline from 2022.
  • Ugi Corp /Pa/ annual Operating Income (Loss) for 2022 was $1.67B, a 29.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $770M +$2.21B Oct 1, 2023 Sep 30, 2024 10-K 2024-11-26
2023 -$1.44B -$3.11B -187% Oct 1, 2022 Sep 30, 2023 10-K 2024-11-26
2022 $1.67B -$684M -29.1% Oct 1, 2021 Sep 30, 2022 10-K 2024-11-26
2021 $2.35B +$1.37B +139% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-29
2020 $982M +$365M +59.2% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-21
2019 $617M -$448M -42.1% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-19
2018 $1.07B +$55M +5.45% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-20
2017 $1.01B +$17.6M +1.77% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-26
2016 $992M +$158M +18.9% Oct 1, 2015 Sep 30, 2016 8-K 2019-05-06
2015 $835M -$171M -17% Oct 1, 2014 Sep 30, 2015 10-K 2017-11-21
2014 $1.01B +$175M +21% Oct 1, 2013 Sep 30, 2014 10-K 2016-11-22
2013 $831M +$293M +54.3% Sep 30, 2012 Sep 30, 2013 10-K 2013-12-16
2012 $539M -$104M -16.2% Oct 1, 2011 Sep 30, 2012 10-K 2014-11-28
2011 $642M -$16.8M -2.55% Sep 30, 2010 Sep 30, 2011 10-K 2013-12-16
2010 $659M Oct 1, 2009 Sep 30, 2010 10-K 2012-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.